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Abstract. 
 
T cell receptor (TCR)-driven activation of 
helper T cells induces a rapid polarization of their cy-
toskeleton towards bound antigen presenting cells 
(APCs). We have identiﬁed the Fyn- and SLP-76–asso-
ciated protein Fyb/SLAP as a new ligand for Ena/
vasodilator-stimulated phosphoprotein (VASP) homol-
ogy 1 (EVH1) domains. Upon TCR engagement, Fyb/
SLAP localizes at the interface between T cells and 
anti-CD3–coated beads, where Evl, a member of the 
Ena/VASP family, Wiskott-Aldrich syndrome protein 
(WASP) and the Arp2/3 complex are also found. In
addition, Fyb/SLAP is restricted to lamellipodia of 
spreading platelets. In activated T cells, Fyb/SLAP as-
sociates with Ena/VASP family proteins and is present 
within biochemical complexes containing WASP, Nck, 
and SLP-76. Inhibition of binding between Fyb/SLAP 
and Ena/VASP proteins or WASP and the Arp2/3 com-
plex impairs TCR-dependent actin rearrangement, sug-
gesting that these interactions play a key role in linking 
T cell signaling to remodeling of the actin cytoskeleton.
Key words: Evl • EVH1 • WASP • Nck • actin cyto-
skeleton
 
Introduction
 
T cells play a central role in immune responses mounted
against pathogens and cancer. Dramatic cytoskeletal reor-
ganization during T cell activation is a prerequisite for a
specific immune response (for references see Penninger
and Crabtree, 1999). Upon binding to an antigen-present-
ing cell (APC),
 
1
 
 the cytoskeleton of a T cell rapidly polar-
izes. The accumulation of actin in a tight collar at the T
cell–APC interface is thought to stabilize a continuous
contact between T cells and APCs (Ryser et al., 1982; Val-
itutti et al., 1995). The formation of this tight contact is ac-
companied by the reorientation of the microtubule-orga-
nizing center towards the contact site to ensure a polarized
release of cytokines or cytotoxic factors (Geiger et al.,
1982; Kupfer et al., 1987, 1991). Although actin remodel-
ing is thought to be essential for T cell activation (see Pen-
ninger and Crabtree, 1999), it is not known how T cell re-
ceptor (TCR) signaling is linked to the rearrangement of
the actin cytoskeleton.
Many of the signaling events that occur in T cells in
response to TCR ligation have been described. TCR en-
gagement induces the activation of tyrosine kinases (Fyn,
Lck, and ZAP-70), leading to the phosphorylation of
several components of the T cell signal transduction path-
way (for reviews see Weiss and Littman, 1994; Clements
et al., 1999). Among the phosphorylated proteins are the
36–38 kD adaptor protein linker for activation of T cells
(LAT) (Zhang et al., 1998a), SH2 domain–containing leu-
kocyte protein of 76 kD (SLP-76) (Jackman et al., 1995),
and a protein of 120–130 kD named Fyn-binding protein
(Fyb) or SLP-76–associated protein of 130 kD (SLAP-
130), which was originally identified independently as an
SH2-binding protein of Fyn and SLP-76, respectively (Da
Silva et al., 1997; Musci et al., 1997). In addition, phosphor-
ylated SLP-76 binds to the SH2 domain of Vav (Tuosto
et al., 1996), a guanine nucleotide exchange factor for Rho
GTPases (Olson et al., 1996; Crespo et al., 1997; Han et al.,
1997). Although Fyb/SLAP has been shown to function in
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TCR-dependent changes in gene expression, such as up-
regulation of IL-2, its precise role in T cell activation has
not been determined (Da Silva et al., 1997; Musci et al.,
1997; Raab et al., 1999).
Impaired T cell function is a hallmark of the Wiskott-
Aldrich syndrome, which is also characterized by throm-
bocytopenia, eczema, and abnormally shaped platelets (for
references see Nonoyama and Ochs, 1998). T cells from
Wiskott-Aldrich syndrome patients show characteristic cy-
toskeletal defects, which are due to mutations in the gene
coding for Wiskott-Aldrich syndrome protein (WASP)
(Derry et al., 1994). WASP is also linked to the actin cy-
toskeleton through binding to the Arp2/3 complex (Ma-
chesky and Insall, 1998), which localizes to sites of actin
assembly such as the lamellipodia or the actin tails of 
 
Lis-
teria monocytogenes
 
 (Kelleher et al., 1995; Machesky et
al., 1997; Welch et al., 1997a,b). In vitro, this complex pro-
motes actin nucleation, which is enhanced by the 
 
Listeria
monocytogenes
 
 virulence factor ActA (Welch et al., 1998),
the sole protein of this intracellular pathogen that is re-
quired for the initiation of actin polymerization at the bac-
terial surface leading to intracellular motility (Domann et al.,
1992; Kocks et al., 1992). In mammalian cells, overexpres-
sion of COOH-terminal fragments of WASP family pro-
teins leads to delocalization of the Arp2/3 complex, result-
ing in the complete loss of lamellipodia and stress fibers
(Machesky and Insall, 1998). Moreover, ectopic expres-
sion of Scar1, a member of the WASP family, in cells com-
pletely blocks 
 
Listeria
 
-induced actin tail formation (May
et al., 1999). These results suggest that the Arp2/3 complex
as well as WASP family proteins act in concert to regulate
the dynamics of the actin cytoskeleton.
The actin-based motility of 
 
Listeria monocytogenes 
 
is
currently one of the best model systems for dissecting ac-
tin dynamics. Among the proteins thought to play a critical
role in 
 
Listeria
 
 motility as well as in cellular processes
requiring dynamic actin rearrangement are those of the
Ena/vasodilator-stimulated phosphoprotein (VASP) fam-
ily (Chakraborty et al., 1995; Gertler et al., 1996; Aszódi et
al., 1999; Lanier et al., 1999; Laurent et al., 1999). By bind-
ing to a specific proline-rich motif (E/DFPPPPXDEE) re-
peated fourfold within ActA, the Ena/VASP homology 1
(EVH1) domain of VASP and Mena targets these proteins
to the bacterial surface (Gertler et al., 1996; Niebuhr et al.,
1997). Related EVH1-binding sites are also present in the
focal contact proteins zyxin (Sadler et al., 1992; Gertler
et al., 1996; Macalma et al., 1996) and vinculin (Brindle et al.,
1996; Reinhard et al., 1996). Several lines of evidence sug-
gest that proteins of the Ena/VASP family function as reg-
ulators of the actin cytoskeleton. First, 
 
Listeria monocy-
togenes
 
 require Ena/VASP proteins for efficient motility.
 
Listeria
 
 expressing mutated versions of ActA, which lack
EVH1-binding sites, fail to recruit Ena/VASP family pro-
teins and move at a reduced speed (Smith et al., 1996; Nie-
buhr et al., 1997). In addition, in cell-free extracts the pres-
ence of Ena/VASP proteins enhances
 
 Listeria
 
 motility
(Loisel et al., 1999). Second, VASP binds in vitro to F-actin
through the EVH2 domain (Reinhard et al., 1992; Bach-
mann et al., 1999; Hüttelmaier et al., 1999; Laurent et al.,
1999). Third, VASP localizes at the front of spreading
lamellipodia (Rottner et al., 1999). Fourth, expression of
the neuronal-specific isoform of Mena induces the for-
mation of actin-rich cell surface projections in fibroblasts.
Furthermore, Mena is highly concentrated at the distal tips
of growth cone filopodia, and genetic analyses indicate
that Mena and its 
 
Drosophila
 
 homologue Ena are required
for axon guidance (Gertler et al., 1996; Lanier et al., 1999;
Wills et al., 1999). Moreover, VASP and Mena are ligands
for profilin (Reinhard et al., 1995; Gertler et al., 1996;
Kang et al., 1997), an actin monomer binding protein that,
under favorable conditions, can stimulate the polymeriza-
tion of actin (Pantaloni and Carlier, 1993). A physiological
role for this interaction is supported by genetic evidence
indicating that Mena and profilin function in concert dur-
ing the actin-driven process of neurulation (Lanier et al.,
1999).
In this report, we describe the identification and charac-
terization of Fyb/SLAP as a new ligand for the EVH1 do-
main of Ena/VASP proteins. In contrast to other known
EVH1 ligands, Fyb/SLAP localizes exclusively to the la-
mellipodia of spreading platelets. Fyb/SLAP is concen-
trated at the contact sites between Jurkat T cells with
anti-CD3–coated beads, where it colocalizes with F-actin,
Ena/VASP proteins, Vav, WASP, and the Arp2/3 com-
plex. Inhibition of the binding between Ena/VASP family
proteins and Fyb/SLAP or between WASP and the Arp2/3
complex abolishes actin remodeling upon TCR ligation.
We propose a model in which Fyb/SLAP, Ena/VASP pro-
teins, and the Arp2/3 complex participate in a regulated
complex that links TCR signaling to actin remodeling dur-
ing T cell activation.
 
Materials and Methods
 
Molecular Cloning and Sequence Analysis
 
Screening of a mouse embryo (d16) expression library 
 
l
 
Exlox (Novagen)
was carried out using polyclonal antibodies raised against the synthetic
peptide SFEFPPPPTDEELRL derived from ActA (Niebuhr et al., 1997).
The expressed sequence tag (EST) clone (IMAGE clone ID 221953;
RZPD IMAGp998F02441) was obtained from the Resource Centre of the
German Human Genome Project (RZPD), Berlin, Germany. Complete
RNA was purified from HL60 cells using Trizol reagent (GIBCO BRL)
according to the manufacturer’s instructions. Reverse transcription (RT)-
PCR was carried out using the First strand synthesis kit according to the
provided instructions (Amersham Pharmacia Biotech). Sequencing and
polymerase chain reactions were performed according to standard proce-
dures.
 
Fusion Proteins and Antibody Production
 
Fragments encoding amino acids 1–339 (Fyb/SLAP I), 341–598 (Fyb/
SLAP III), 548–783 (Fyb/SLAP IX) of Fyb/SLAP1 (numbering according
to Da Silva et al., 1997; Musci et al., 1997), and the NH
 
2
 
 terminus of mu-
rine WASP (amino acids 1–256; Derry et al., 1995) were generated by
PCR and cloned into the pGEX-2TK, pGEX-6P1, or pGEX-5X3 vectors
(Amersham Pharmacia Biotech). Fusion proteins were purified on glu-
tathione–Sepharose (Amersham Pharmacia Biotech) or glutathione-aga-
rose (Pierce). Immobilized Fyb/SLAP III glutathione 
 
S
 
-transferase (GST)
was digested with thrombin (Amersham Pharmacia Biotech) and used to
raise the polyclonal rabbit antiserum #51 (Eurogentec Bel S.A.), which
was affinity-purified using Fyb/SLAP III GST Sepharose. The antiserum
#81 was raised against the synthetic peptide 656-LKGKDDRKKSIREK-
PKV-672 derived from Fyb/SLAP2 (see Fig. 1 D) and affinity-purified us-
ing the same peptide immobilized on EAH-Sepharose (Amersham Phar-
macia Biotech). The Arp3 polyclonal antibody B7I was raised against the
synthetic peptide 342-(C)TVDARLKLSEELSGGRLKPK-361 derived
from bovine Arp3 sequence (sequence data available from EMBL/Gen-
Bank/DDBJ under accession no. P32391) and affinity-purified using the
same peptide immobilized on EAH-Sepharose (Pharmacia). The proteins 
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Fyb/SLAP I, III, IX GST prepared from pGEX-6P1 constructs, digested
with Prescission™ protease (Pharmacia), and GST-WASP were used to
raise mAbs as described previously (Niebuhr et al., 1998). A detailed anal-
ysis of the mAbs against Fyb/SLAP will be presented elsewhere (Krause,
M., and J. Wehland, manuscript in preparation).
 
Biochemistry
 
The extracts of Jurkat E6-1 cells were prepared in two different ways. For
the binding assays, Jurkat E6-1 cells were stimulated for 1 min with 0.2 mM
Na
 
3
 
VO
 
4
 
, 8 mM H
 
2
 
O
 
2
 
 (pervanadate), which mimics the effect of TCR liga-
tion in Jurkat cells (Secrist et al., 1993; Motto et al., 1994). Jurkat RIPA ly-
sates were prepared in ice-cold RIPA buffer (25 mM Tris-HCl, pH 7.5,
150 mM NaCl, 1% NP-40, 0.5% deoxycholate, and 0.1% SDS) supple-
mented with 1 mM PMSF. Immunoprecipitations were carried out accord-
ing to standard protocols, using the VASP mAb IE226C2 (Abel et al.,
1996) and the WASP antiserum Fus3 (Symons et al., 1996). As negative
controls, anti-ActA mAbs (358C1) (Niebuhr et al., 1993) and a rabbit
nonimmune serum were used. For immunoprecipitation, 0.2 ml of Jurkat
RIPA lysate (derived from 1.6 
 
3
 
 10
 
7
 
 cells) was used.
For dissection of the complex Jurkat E6-1 cells were starved overnight
in RPMI 1640 (GIBCO BRL) supplemented with 1% (vol/vol) FCS and
2 mM 
 
L
 
-glutamine (GIBCO BRL). The next day, the Jurkat cells were
washed two times with ice-cold RPMI 1640 media without supplements
and resuspended at 5 
 
3 
 
10
 
7
 
 cells/ml in ice-cold DME/Hepes (GIBCO
BRL). OKT3 anti-CD3 antibodies (CRL-8001; ATCC) were added to a fi-
nal concentration of 3 
 
m
 
g/ml for stimulation, or no antibodies as control,
and cells were kept on ice for 15 min. After quick pelleting, stimulated and
control cells were resuspended and incubated in DME/Hepes containing
15 
 
m
 
g/ml goat anti–mouse IgG antibodies at 37
 
8
 
C for 2 min. Jurkat NP-40
lysates were prepared at 1 
 
3
 
 10
 
8
 
 cells/ml in ice-cold NP-40 lysis buffer (1%
[vol/vol] NP-40, 150 mm NaCl, 10 mM Tris-Cl, pH 7.8) supplemented with
60 
 
m
 
g/ml chymostatin, 10 
 
m
 
g/ml pepstatin, 5 
 
m
 
g/ml leupeptin, 2 
 
m
 
g/ml
aprotinin, 2 mM Pefabloc (Roche), 1 mM Na
 
3
 
VO
 
4
 
, and 10 mM NaF. For
immunoprecipitations, affinity columns were prepared with the WASP
mAb 67B4, and as control, with the anti-ActA 358C1 mAbs (Niebuhr et
al., 1993) using CNBr–Sepharose (Pharmacia). Immunoprecipations were
carried out according to standard protocols, using 0.2 ml of Jurkat NP-40
lysates derived from 2 
 
3
 
 10
 
7
 
 cells. Immunoprecipitates were resolved by
SDS-PAGE. As positive control, Jurkat E6-1 lysates were used. Blots
were probed with the following antibodies to: Fyb/SLAP #51, Nck (Trans-
duction Labs), SLP-76 (Transduction Labs), zyxin 164D4 (Krause et al.,
manuscript in preparation), and phosphotyrosine 4G10 (Upstate Biotech-
nology), and processed using ECL or ECL plus enhanced chemilumines-
cence detection kits (Amersham).
 
Protein Overlay Assays
 
35
 
S-labeled full-length VASP and the 80-kD isoform of Mena were pre-
pared in vitro using the TNT™ coupled transcription–translation system
(Promega). The cDNA of the ActA repeats (amino acids 241–423; num-
bering as in Domann et al., 1992) was amplified by colony PCR from 
 
L
 
.
 
monocytogenes
 
 strain EGD and cloned into the pGEX-6P1 vector (Amer-
sham Pharmacia Biotech). The murine clone 5/7 was cloned in the pGEX-
6P1 vector (Amersham Pharmacia Biotech). Protein overlay assays were
done as described previously (Chakraborty et al., 1995; Niebuhr et al.,
1997). Spot synthesis was performed according to Frank (1992). Mem-
branes were analyzed using a PhosphorImager (Molecular Dynamics).
 
Cell Culture and Fluorescence Microscopy
 
Platelets were obtained from the local blood bank, diluted in 10 mM
Hepes, pH 7.4, 5 mM KCl, 145 mM NaCl, 10 mM glucose, 1 mM MgCl
 
2
 
,
1 mM CaCl
 
2
 
, and placed on glass coverslips. Platelets were allowed to set-
tle and spread for 30 min in a humid chamber at 37
 
8
 
C. Jurkat E6-1 (TIB
152; ATCC) were grown in RPMI 1640 (GIBCO BRL), supplemented
with 10% FCS and 2 mM 
 
L
 
-glutamine (GIBCO BRL). For the bead assay,
goat anti–mouse IgG dynabeads M-450 (Dynal) were coated with anti-
CD3 mAb TR66 (Lanzavecchia and Scheidegger, 1987). Coated beads
and Jurkat cells were washed with and resuspended in DME/Hepes
(GIBCO BRL) supplemented with 1% FCS. They were then mixed and
incubated on ice for 30 min followed by 4 min at 37
 
8
 
C. Cells were allowed
to attach on poly-
 
L
 
-lysine–coated coverslips for 2 min on ice, fixed with
3% (wt/vol) paraformaldehyde in cytoskeleton buffer, pH 7.0, and perme-
abilized with 0.1% (vol/vol) Triton X-100 in cytoskeleton buffer, pH 7.0.
 
The zone of contact between Jurkat T cells and anti-CD3–coated beads
was evaluated by measuring the length of the circular arc of contact ac-
cording to the formula 
 
a3
 
(
 
p
 
/180)
 
3
 
r, where 
 
a
 
 is the angle of the circular
sector (in degrees) and r is the radius of the bead (in 
 
m
 
m). The radius of
the bead is 2.25 
 
m
 
m.
Fixation and immunofluorescence microscopy were done as already
described (May et al., 1999) using the following antibodies: Fyb/SLAP #51
and 155E8, vinculin hvin1 (Sigma Chemical Co.), VASP IE226C2 (Abel
et al., 1996), WASP (Fus3; Symons et al., 1996), Vav (mAb Vav-30; Sattler
et al., 1995), Ena/VASP-like (Evl) (mAb 84H1; Lanier et al., 1999), zyxin
164D4 (Krause et al., manuscript in preparation), and Arp3 B7I. CY3-
phalloidin was a kind gift of Dr. H. Faulstich (Heidelberg). Fluorescently-
labeled secondary antibodies were purchased from Dianova. The mAb
9E10 against the myc tag was purchased from ATCC (clone no. CRL-
1729). Image analysis was carried out as already described (May et al.,
1999).
 
Green Fluorescent Protein (GFP) Constructs and 
Transfection Procedures
 
The cDNA of the ActA repeats (amino acids 241–423; numbering as in
Domann et al., 1992) was amplified by colony PCR from 
 
L
 
.
 
 monocytoge-
nes
 
 strain EGD. The cDNA of the mutated ActA repeats was kindly pro-
vided by Dr. Susanne Pistor (Gesellschaft für Biotechnologische For-
schung, Braunschweig, Germany). The wild-type and mutant repeats were
tagged with pEGFP-N1 (Clontech). The myc-tagged ScarW and ScarWA
were kindly provided by Dr. Laura M. Machesky (University of Birming-
ham, Birmingham, UK). Transfection in HeLa cells was performed with
FuGENE (Boehringer Mannheim) according to manufacturer’s instruc-
tions. Jurkat E6-1 cells (1 
 
3
 
 10
 
7
 
 cells resuspended in DME/Hepes) were
transfected with 40 
 
m
 
g of cDNA by electroporation using a Gene Pulser II
(BioRad) with the following settings: voltage, 0.25 kV; capacitance, 950 
 
m
 
F.
 
Scanning EM
 
For scanning EM, Jurkat T cells were transiently transfected with GFP-
ActA repeats or GFP-ActA repeats F
 
 . 
 
A and sorted using a FACS
sorter (FACS Vantage; Becton Dickinson). This approach was necessary
to obtain a cell population expressing equivalent levels of GFP-tagged
proteins, and facilitated the analysis of the cells by scanning EM. Jurkat T
cells expressing moderate to high levels of GFP-ActA repeats or GFP-
ActA repeats F
 
 . 
 
A were used for analysis. Sorted cells were returned to
the incubator and allowed to recover overnight. After the bead assay, Jur-
kat T cells were fixed with 3% paraformaldehyde in cytoskeleton buffer,
pH 7.0, for 30 min on ice, then washed with the cytoskeleton buffer. Cells
were postfixed with 2.5% glutaraldehyde in cacodylate buffer (0.1 M so-
dium cacodylate, 0.09 M sucrose, 10 mM MgCl
 
2
 
, 10 mM CaCl
 
2
 
, pH 7.2) for
2 h at room temperature. After washing with cacodylate buffer, the cells
were dehydrated through a graded series of ethanol, processed by critical-
point drying, and gold coated. Samples were examined with a digital scan-
ning electron microscope (DSM 982 Gemini; Zeiss) using a working dis-
tance of 2–4 mm and acceleration voltage of 5 Kv. EM images were
processed using Photoshop 5.0 (Adobe Systems, Inc.).
 
Results
 
Molecular Cloning of Fyb/SLAP as a Novel
EVH1 Ligand
 
We observed previously that polyclonal antibodies raised
against the EVH1-binding motif of ActA reacted with
vinculin, zyxin, and several unidentified bands on West-
ern blots of HeLa cell lysates (Niebuhr et al., 1997). In
an attempt to identify novel EVH1-binding proteins, we
screened a mouse embryonic expression library with these
antibodies and obtained 15 positive clones. One of those
(clone 5/7) bound to the 
 
32
 
P-labeled GST-EVH1 domain
of Mena (Niebuhr et al., 1997) in a blot overlay assay (data
not shown). Screening of the EST database with the se-
quence of the 5/7 partial clone revealed a human EST clone
(IMAGE clone ID 221953; RZPD IMAGp998F02441) 
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that contained a 2.3-kb cDNA encoding an unknown pro-
tein (Fig. 1 a). During the characterization of this protein,
two identical protein sequences, termed Fyb (Da Silva et al.,
1997) or SLAP-130 (Musci et al., 1997), were reported.
The EST clone was identical to the published sequence of
Fyb/SLAP except for an additional insertion of 131 bp and
a frame shift that leads to an earlier termination of transla-
tion. Three independent RT-PCRs of the COOH terminus
 
of Fyb/SLAP showed two bands of 700 and 840 bp, indi-
cating that two isoforms of Fyb/SLAP, at least in the hu-
man myeloid cell line HL60, exist (Fig. 1 b). The se-
quences of these fragments indicated that the longer
isoform contains an insertion of 138 bp and has the same
COOH terminus as Fyb/SLAP. The 700-bp fragment cor-
responds to the published sequence. A full-length Fyb/
SLAP clone without the 138-bp insertion was obtained by
RT-PCR and termed Fyb/SLAP1. The full-length cDNA
clone of the longer Fyb/SLAP isoform was amplified by
PCR using the EST clone and the 840-bp RT-PCR frag-
ment as templates, and was termed Fyb/SLAP2 (Fig. 1 a).
Very recently, the murine homologue of Fyb/SLAP 2 has
been reported (Veale et al., 1999).
 
Domain Structure and Isoforms of Fyb/SLAP
 
We have recently characterized the core sequence of the
EVH1-binding site as F/Y/L/WPPPP (Niebuhr et al.,
1997). Fyb/SLAP harbors four similar motifs (Fig. 1, a and
d). However, only two of them contain the adjacent acidic
residues that are essential for binding to EVH1 domains as
shown previously for the analogous motifs of ActA (Nie-
buhr et al., 1997; Carl et al., 1999).
Two highly charged regions are also present within Fyb/
SLAP (Fig. 1 d; amino acids 451–500 and 673–700). Inter-
estingly, the first highly charged sequence shows a striking
similarity with part of the NH
 
2
 
-terminal sequence of the 
 
L.
monocytogenes
 
 protein ActA, which is involved in the actin
recruitment by 
 
Listeria
 
 (Fig. 2 a) (Pistor et al., 1995; Lasa et
al., 1995, 1997). The region following the first highly
charged region of Fyb/SLAP (amino acids 566-581) shows
high homology with the known G-actin binding site of thy-
mosin 
 
b
 
4 (Van Troys et al., 1996), the human villin head-
piece (Friederich et al., 1992), the putative G-actin binding
site of the dematin headpiece (Van Troys et al., 1996), and a
potential G-actin binding site of Ena/VASP proteins (Gertler
et al., 1996) (Fig. 2 b). The 46–amino acid insertion in Fyb/
SLAP2 is highly charged and shows no homology with
known motifs. The COOH terminus harbors an SH3-like do-
main (Fig. 1 d) (Da Silva et al., 1997; Musci et al., 1997).
To analyze Fyb/SLAP in more detail, a polyclonal anti-
serum (#51) was raised against and affinity-purified with a
recombinant Fyb/SLAP fragment covering the central do-
main common to both isoforms (Fyb/SLAP III GST; Fig. 1
a). This antibody specifically reacted with a 120-kD band in
Jurkat T cell extracts and with two bands of 120 and 130 kD
in extracts of human platelets (Fig. 1 c). Moreover, this an-
tiserum did not react with extracts of nonhematopoietic
cell lines such as HeLa (data not shown). An additional
antiserum (#81) was raised against a synthetic peptide de-
rived from the unique sequence of Fyb/SLAP2. On im-
munoblots of human platelet extracts these polyclonal
antibodies reacted with a 130-kD band (the few bands de-
tected below the 130-kD band most probably represent
degradation products) (Fig. 1 c), indicating that the dou-
blet detected with the antiserum #51 is indeed due to the
insertion present in the Fyb/SLAP2 isoform.
 
Fyb/SLAP Is a New EVH1-binding Protein
 
Since Fyb/SLAP harbors four potential EVH1-binding
sites, we sought to determine which of these binding sites
Figure 1. (a) Schematic representation of the full-length Fyb/
SLAP2, the EST clone (IMAGE clone ID 221953; RZPD
IMAGp998F02441), the murine clone 5/7, and the three GST fu-
sion proteins encoding for different regions of Fyb/SLAP2 (Fyb/
SLAP I, III, and IX). Potential EVH1 domain–binding sites,
SH3-like domain, and the 138-bp insertion are also shown. (b)
RT-PCR of the COOH terminus of Fyb/SLAP as obtained from
HL60 cells shows two bands running at z700 and 840 bp (lanes
1–3, RT-PCRs of three independent experiments; lane 4, 100 bp
marker). (c) Immunodetection of Fyb/SLAP in extracts of hu-
man platelets and Jurkat T cells. The affinity-purified polyclonal
antibody #51 specifically reacts with a single band on Jurkat T
cells lysate and with two bands on platelet extract, whereas the
polyclonal antibody #81 reacts with a single band on platelet ex-
tract. (d) Amino acid sequence and structural motifs of Fyb/
SLAP2. Single letter amino acids sequence of Fyb/SLAP2. Boxes
represent potential EVH1 domain–binding sites, stretch of bold-
faced amino acids represents the insertion not present in Fyb/
SLAP1. Potential SH3-binding regions (underlined), potential
tyrosine phosphorylation sites (bold and boxed), and the SH3-
like domain (dotted) are shown. The sequence of Fyb/SLAP2 is
available from EMBL/GenBank/DDBJ under accession no.
AF198052. 
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interacts with VASP and Mena using a ligand overlay as-
say. The COOH terminus of Fyb/SLAP (Fyb/SLAP IX
GST; Fig. 1 a), which harbors two potential binding sites,
interacted with in vitro translated 
 
35
 
S-labeled VASP,
whereas the central part of the protein (Fyb/SLAP III
GST; Fig. 1 a) and its NH
 
2
 
 terminus (Fyb/SLAP I GST;
Fig. 1 a) did not (Fig. 3 a). The same results were obtained
using in vitro translated 
 
35
 
S-labeled Mena (data not
shown). Thus, the COOH terminus of Fyb/SLAP interacts
directly with VASP and Mena in vitro. To map the binding
site more precisely, we performed a ligand overlay assay
on scans of arrayed peptides covering the complete Fyb/
SLAP1 sequence and the COOH terminus of Fyb/SLAP2
(Fig. 3 b) as recently described for the identification of the
EVH1-binding sites of ActA (Niebuhr et al., 1997). As
shown in Fig. 3 c, the binding site for the EVH1 domain
corresponds to the motif 616-FPPPPDDDI-624 (Fig. 1 d).
To determine if Fyb/SLAP and VASP associate in vivo,
we prepared immunoprecipitates of VASP from lysates of
activated human Jurkat T cells. The VASP immunoprecip-
itates contained Fyb/SLAP (Fig. 3 d). These data indicate
that endogenous VASP and Fyb/SLAP are present in a
protein complex within hematopoietic cells.
 
Fyb/SLAP Localizes to Sites of High Actin Dynamics
 
EVH1-binding motifs have been found in the cytoskeletal
proteins zyxin and vinculin as well as in the 
 
Listeria
 
 pro-
tein ActA (Brindle et al., 1996; Reinhard et al., 1996; Nie-
buhr et al., 1997). These motifs are required for the proper
subcellular targeting of Ena/VASP family proteins. There-
fore, we analyzed the distribution of Fyb/SLAP in hemato-
poietic cells. In glass-activated spreading, human platelets
Fyb/SLAP localized exclusively to lamellipodia (Fig. 4 a)
where, in part, it overlapped with VASP (Fig. 4, b–b
 
99
 
),
which in addition, was also detectable in focal adhesions as
shown previously (Reinhard et al., 1992). In contrast to
Fyb/SLAP, zyxin (for references see Beckerle, 1997) and
vinculin (for references see Jockusch et al., 1995) were
predominantly detected in focal contacts (Fig. 4, c, c
 
9
 
, d,
and d
 
9
 
), although we also found vinculin in lamellipodia as
described previously (Takubo et al., 1998). The same dis-
 
tribution of Fyb/SLAP in spreading platelets was also ob-
tained using the mAb 155E8 raised against Fyb/SLAP1
(data not shown).
Since Fyb/SLAP is a component of the TCR signaling
Figure 2. (a) Alignment of protein sequences of the NH2 termi-
nus of ActA (from L. monocytogenes), iActA (from L. ivanovii),
and Fyb/SLAP. Identical amino acids are indicated with bold let-
ters, homologous amino acids are underlined. Amino acids are
numbered according to Domann et al. (1992) for ActA and to
Kreft et al. (1995) for iActA. (b) Alignment of the G-actin bind-
ing sites of thymosin b4, villin, dematin, the potential G-actin
binding site of Mena, and Fyb/SLAP. Amino acids involved in
the binding to G-actin are indicated with bold letters. Homolo-
gous amino acids are underlined.
Figure 3. (a) Blot overlay assay of in vitro translated 35S-labeled
VASP on GST fusion proteins of Fyb/SLAP and the murine
clone 5/7. (lane 1) GST-ActA proline-rich repeats (positive con-
trol), (lane 2) Fyb/SLAP I GST, (lane 3) Fyb/SLAP III GST,
(lane 4) Fyb/SLAP IX GST, and (lane 5) murine clone 5/7 GST.
Note that bands representing degradation products are visible in
lanes 1, 4, and 5. (b) Peptide spot analysis of the full-length Fyb/
SLAP1 and of the COOH terminus of Fyb/SLAP2. Peptides
were synthesized on a cellulose membrane and incubated with
35S-labeled VASP. Positive spots were detected with a Phosphor-
Imager. (c) Single letter amino acid sequences of the peptides
corresponding to the positive spots shown in b. (d) Coimmuno-
precipitation of Fyb/SLAP and VASP from a lysate of Jurkat T
cells. Extracts of activated Jurkat T cells were incubated with
mAbs against VASP. Immune complexes were collected using
anti–mouse IgG agarose. Bound proteins were separated by
SDS-PAGE, blotted, and probed with the affinity-purified anti-
body #51 to Fyb/SLAP. (lane 1) Lysate of activated Jurkat T cells
(positive control), (lane 2) proteins immunoprecipitated using
the mAb (358C1) raised against a bacterial protein, and (lane 3)
proteins immunoprecipitated using anti-VASP specific mAbs.
Molecular weight markers are indicated on the left in a and d. 
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complex, we examined the distribution of Fyb/SLAP in ac-
tivated T cells. Jurkat T cells become polarized towards
anti-CD3–coated beads and reorganize their actin cyto-
skeleton as a dense F-actin collar. Furthermore, F-actin–
rich pseudopods protrude from the T cell surface to in-
crease the contact area at the beads–T cells attachment
sites. This approach mimics the actin reorganization taking
place during T cell–APC interaction and permits the pre-
cise analysis of typical actin remodeling of T cells (Lowin-
Kropf et al., 1998). We analyzed Jurkat T cells that bound
to one bead. In addition, only T cell–bead conjugates in
which both the T cell and the bead were in the same plane
of focus were considered suitable for analysis. This en-
abled us to unambiguously identify the actin collar and
achieve consistent results from different bead assays. In-
terestingly, Fyb/SLAP accumulated at the T cell–beads at-
tachment sites where it colocalized with F-actin (Fig. 5 a
 
9
 
).
Since Evl is the member of the Ena/VASP family proteins
that is most enriched in hematopoietic cells (Lanier et al.,
1999), we considered its localization in T cells as represen-
tative of the Ena/VASP proteins in general. Evl localized
to the contact sites between T cells and beads (Fig. 5 b
 
9
 
).
In addition, WASP, the Arp2/3 complex, e.g., Arp3, and
Vav also localized at the T cell–bead interface (Fig. 5, c
 
9
 
–e
 
9
 
),
whereas vinculin and zyxin did not accumulate at these
contact sites (Fig. 5, f
 
9 
 
and g
 
9
 
).
 
Ena/VASP Family Proteins Are Essential for
the Remodeling of the Actin Cytoskeleton upon
TCR Ligation
 
We sought to determine whether recruitment of Ena/
VASP proteins is required for actin remodeling of acti-
vated T cells. We reasoned that disrupting the interaction
between EVH1 domain and its ligands would neutralize
the function of Ena/VASP proteins by preventing their
proper subcellular targeting and association with natural
ligands. The affinities of the Ena/VASP family proteins for
the EVH1-binding sites of ActA are higher than those for
their natural ligands (Niebuhr et al., 1997). Microinjec-
tion of a peptide containing an ActA EVH1-binding mo-
tif (FEFPPPPTDEELRL) displaces Ena/VASP proteins
from the focal adhesions, whereas a mutated peptide
(FEAPPPPTDEELRL) has no effect (Pistor et al., 1995;
Gertler et al., 1996; Niebuhr et al., 1997). To overcome
the difficulty in microinjecting T cells and to allow a rapid
identification of transfected cells, the four EVH1-binding
sites of ActA (ActA repeats) were tagged with the GFP
(GFP-ActA repeats). As control, a GFP-tagged mutated
variant of the four EVH1 domain–binding sites in which
the phenylalanine residues preceding the four prolines
of each repeat have been mutated to alanine was used
(GFP-ActA repeats F
 
 . 
 
A). As a positive control for this
approach, HeLa cells were transfected with GFP-ActA re-
peats. Focal adhesions in the GFP-ActA repeats express-
ing cells were obviously devoid of VASP, whereas cells
transfected with GFP-ActA repeat F
 
 . 
 
A showed typical
robust labeling of focal adhesions with VASP (Fig. 6, a
and b
 
9
 
). The GFP-ActA repeats were then introduced into
Jurkat T cells to test the effect of displacing Ena/VASP
proteins on TCR-driven actin rearrangement. Jurkat T
cells expressing the GFP-ActA repeats bound to anti-
CD3–coated beads but did not form the typical actin collar
at the T cell–bead interface (Fig. 6, c and c
 
9
 
). In control un-
transfected cells, the length of the contact zone was 5.38 
 
m
 
m
(SD 
 
5 
 
0.98 
 
m
 
m, 
 
n 
 
5 
 
32), whereas in T cells transfected
with the GFP-ActA repeats the zone of contact was signif-
icantly reduced (3.84 
 
6
 
 0.95 
 
m
 
m, 
 
n 
 
5 
 
46). As a conse-
quence of the impaired actin remodeling, the F-actin accu-
mulation was undetectable at this contact site. In contrast,
cells expressing the GFP-ActA repeats F
 
 . 
 
A exhibited
normal F-actin accumulation (Fig. 6, d and d
 
9
 
) as well as
length of the contact zone (5.16 
 
6
 
 1.33 
 
m
 
m, 
 
n 
 
5 
 
30) at the
T cell–bead interface. To investigate whether or not these
effects on actin accumulation and length of the contact
zone were accompanied by clear morphologic effects, we
decided to analyze the interaction between T cells and
beads by scanning EM in more detail. We found that T
cells expressing GFP-ActA repeats simply contacted but
did not surround CD3-coated beads (Fig. 7 b), whereas
control T cells or cells expressing GFP-ActA repeats F
 
 .
 
A almost completely surrounded the beads with sheet-like
extensions (Fig. 7, a and c). Thus, we conclude that pro-
teins of the Ena/VASP family are essential for actin re-
modeling upon T cell stimulation. We also analyzed the
distribution of Evl, Fyb/SLAP, WASP, and the Arp2/3
complex in stimulated T cells. In Jurkat T cells transfected
with the GFP-ActA repeats, Evl did not localize at the T
cell–bead interface (Fig. 6 e), whereas the distribution of
Fyb/SLAP, WASP, and the Arp2/3 complex was unaf-
fected (Fig. 6, f–h). The localization of these proteins at
the T cell–bead interface was unaffected in T cells trans-
fected with GFP-ActA repeats F
 
 . 
 
A (data not shown).
Figure 4. Fluorescence micrographs showing the localization of
Fyb/SLAP and cytoskeletal proteins in human platelets. Platelets
were allowed to attach and spread on glass coverslips, fixed, and
double stained for Fyb/SLAP (a–d), actin (a9), VASP (b9), zyxin
(c9), or vinculin (d9). (b99) Merged picture of Fyb/SLAP (b) and
VASP (b9). Bars, 5 mm.Krause et al. TCR Signaling to the Actin Cytoskeleton 187
The Arp2/3 Complex Is Required for the 
Reorganization of the Actin Cytoskeleton in T Cells
Based on our observation that WASP and the Arp2/3
complex localize to the attachment sites between T cells
and anti-CD3–coated beads, and given that WASP family
proteins directly interact with the Arp2/3 complex, we
predicted that the Arp2/3 complex is involved in actin dy-
namics in T cells. The COOH-terminal domain of Scar,
ScarWA, is similar to the COOH-terminal region of
WASP and disrupts the binding of WASP family proteins
to the Arp2/3 complex when expressed in mammalian cells
(Machesky and Insall, 1998). Overexpression of ScarWA,
which binds to G-actin and the p21Arc subunit of the
Arp2/3 complex, delocalizes the Arp2/3 complex and
causes the loss of lamellipodia and stress fibers in Swiss3T3
fibroblasts and J774 macrophages. In addition, ScarWA in-
hibits the Listeria-induced actin tail formation in infected
cells as well as in mouse brain extract. In contrast, ScarW,
which binds to G-actin only, has no effect (Machesky and
Insall, 1998; May et al., 1999). To investigate the role of the
Arp2/3 complex in the reorganization of the T cell actin cy-
toskeleton in response to TCR engagement, we overex-
pressed myc-tagged Scar1 fragments in T cells. In Jurkat T
cells transfected with ScarWA, F-actin accumulation at the
T cell–bead interface was not detectable, whereas it was
not affected in Jurkat T cells transfected with ScarW (Fig.
8, a–b9). Moreover, the length of the contact zone between
the beads and Jurkat T cells was significantly reduced
(3.16 6 0.78 mm, n 5 39), whereas in ScarW-transfected
cells the size of the contact zone was comparable to that of
control cells (5.00 6 1.08 mm, n 5 22). The expression of
ScarWA affected the distribution of the Arp2/3 complex,
which was no longer detectable at the T cell–bead inter-
face (Fig. 8 f), whereas Evl, Fyb/SLAP, and WASP still ac-
cumulated at this site (Fig. 8, c–e). As expected, the ex-
pression of ScarW did not affect the localization of these
proteins (data not shown). These data indicate that in ad-
dition to the Ena/VASP proteins, the Arp2/3 complex is
essential for the reorganization of the actin cytoskeleton
taking place during T cell activation.
Fyb/SLAP, SLP-76, Nck, and WASP Are Constituents 
of a Complex in T Cells
Since Fyb/SLAP and WASP localized to the contact site
between activated Jurkat T cells and anti-CD3–coated
beads, we speculated that both proteins might be constitu-
ents of a complex in activated Jurkat T cells. This possibil-
ity is consistent with recent findings indicating that Fyb/
Figure 5. Distribution of
Fyb/SLAP in activated T
cells. Jurkat T cells were
incubated with anti-CD3–
coated beads (a9, asterisk)
and allowed to settle on glass
coverslips. T cells were then
double stained for F-actin
(a–g), Fyb/SLAP (a9), Evl
(b9), WASP (c9), Arp3 (d9),
Vav (e9), vinculin (f9), or
zyxin (g9). Fyb/SLAP is en-
riched at the interface be-
tween the activated T cell
and the anti-CD3–coated
bead (a9, arrow). F-actin also
colocalizes with Evl, WASP,
Arp3, and Vav (arrows in b9,
c9, d9, and e9 respectively). In
contrast, vinculin and zyxin
do not accumulate at the in-
terface between T cells and
beads (e9 and f9). Note that
beads are visible in the pan-
els e9–g9 due to the binding
of the secondary goat anti–
mouse antibody to the mAbs
against CD3 used to coat the
beads. Bar, 5 mm.The Journal of Cell Biology, Volume 149, 2000 188
SLAP binds to the SH2 domain of SLP-76 (Da Silva et al.,
1997; Musci et al., 1997), which forms a ternary complex
with Vav and Nck (Bubeck Wardenburg et al., 1998). In
addition, Rivero-Lezcano et al. (1995) show that the SH3
domain of Nck binds to WASP. To test this hypothesis,
immunoprecipitates from extracts of activated Jurkat T
cells were prepared using an antiserum against WASP.
Western blot analysis demonstrated that the immunopre-
cipitates contained Fyb/SLAP, indicating that it is present
in a protein complex with WASP in vivo (Fig. 9 a).
To further investigate the composition of this complex,
we prepared immunoprecipitates from Jurkat T cell ex-
tracts using the WASP mAb 67B4. This antibody proved
to be more suitable than the polyclonal to WASP for im-
munoprecipitation studies. Immunoprecipitates prepared
from anti-CD3 stimulated Jurkat T cells were analyzed us-
ing antibodies to Fyb/SLAP, SLP-76, and Nck. We identi-
fied these three proteins in WASP immunoprecipitates, in-
dicating that they each are present in complexes that
contain WASP (Fig. 9 b). Since Fyb/SLAP binds directly
to SLP-76 (Da Silva et al., 1997; Musci et al., 1997) and
SLP-76 associates with Vav and Nck (Bubeck Warden-
burg et al., 1998), all of these molecules may be associated
with WASP in a single multiprotein complex. To rule out
any unspecific trapping, we probed the same immunopre-
cipitates with the mAb to zyxin, which is not detectable at
the interface between Jurkat T cells and beads. As ex-
pected, zyxin is not immunoprecipitated with WASP,
proving the specificity of our approach. As negative con-
trols, we prepared immunoprecipitates using an antibody
to a bacterial protein; these immunoprecipitates contained
neither Fyb/SLAP, SLP-76, nor Nck (Fig. 9 b). To investi-
gate whether the complex composed of Fyb/SLAP, SLP-
76, Nck, and WASP formed upon activation of T cells, T
cell lysates from nonstimulated cells were immunoprecipi-
tated with the WASP mAb and probed with antibodies to
Fyb/SLAP, SLP-76, and Nck. These proteins could be de-
tected in these precipitates, indicating that they also form
Figure 6. (a–b9) Displace-
ment of Ena/VASP family
proteins by the proline-rich
repeats of ActA. HeLa cells
were transfected with GFP-
ActA repeats (a and a9) or
with the mutant GFP-ActA
repeats F . A (b and b9),
fixed, and labeled with anti-
bodies to VASP (a and b,
VASP labeling; a9 and b9,
GFP signal). In untrans-
fected cells, VASP localizes
to focal adhesions (a, ar-
rows). In cells expressing the
GFP-ActA repeats (a, aster-
isks), VASP is displaced
from the focal adhesions. In
contrast, cells transfected
with the mutated ActA re-
peats (for instance, asterisks
in b) show a normal VASP
localization (b, arrows). (c–
h9) Inhibition of F-actin ac-
cumulation at the interface
between Jurkat T cells and
anti-CD3–coated beads. Jur-
kat T cells were transfected
with GFP-ActA repeats (c
and c9) or with the mutant
GFP-ActA repeats F . A (d
and d9). Note the lack of ac-
tin accumulation at the T
cell–bead interface and the
reduced zone of contact be-
tween T cell and bead (c, ar-
row). Such actin accumula-
tion is not affected in Jurkat
T cells that were transfected with the mutated ActA repeats (d, arrow; c and d, fluorescent phalloidin; c9 and d9, GFP signal). (e–h9) The
localization of Evl but not that of Fyb/SLAP, WASP, and the Arp2/3 complex at the T cell–bead interface is affected by the proline-rich
repeats of ActA. Jurkat T cells were transfected with GFP-ActA repeats, incubated with anti-CD3–coated beads, fixed, and labeled
with antibodies to Evl (e), Fyb/SLAP (f), WASP (g), and Arp3 (h) (e9–h9, GFP signal). In cells expressing the GFP-ActA repeats, Evl is
displaced from the T cell–bead contact sites (e, arrow). In contrast, the localization of Fyb/SLAP, WASP, and the Arp2/3 complex is
unaffected. Bars: 10 mm (a–b9); and 5 mm (c–h9).Krause et al. TCR Signaling to the Actin Cytoskeleton 189
a complex in nonstimulated T cells (Fig. 9 b). However,
the relative amount of the complex in stimulated T cells
seemed to be higher than that in nonstimulated cells, sug-
gesting that the formation of such complex is, in part, stim-
ulation-dependent. Tyrosine phosphorylation is a key step
during T cell activation. At least two of the proteins in-
volved in the complex, Fyb/SLAP and SLP-76, are ty-
rosine phosphorylated in response to T cell stimulation
(Clements et al., 1999). Therefore, we analyzed the ty-
rosine phosphorylation pattern of WASP immunoprecipi-
Figure 7. Scanning EM analysis of the interaction between Jur-
kat T cell and anti-CD3–coated beads. Untransfected Jurkat T
cells (a), T cells transfected with GFP-ActA repeats (b), and T
cells transfected with GFP-ActA repeats F . A (c) were incu-
bated with anti-CD3–coated beads, fixed, and processed for scan-
ning EM. Jurkat T cells, which expressed GFP-ActA repeats,
formed a very loose contact with the bead. In contrast, control T
cells or cells which expressed the mutated GFP-ActA repeats ex-
tended sheet-like protrusions that almost completely surrounded
the beads. Bar, 5 mm.
Figure 8. (a–b9) Delocalization of the Arp2/3 complex by the
COOH terminus of Scar1 inhibits the actin reorganization at the
T cell–bead interface. Jurkat T cells were transfected with myc-
tagged ScarWA (a and a9) or ScarW (b and b9), incubated with
anti-CD3–coated beads, fixed, and stained with fluorescent phal-
loidin and anti-myc antibodies. In Jurkat T cells, which expressed
ScarWA, the actin accumulation at the T cell–bead interface is
impaired (a, arrow), whereas T cells transfected with ScarW
show a normal actin rearrangement (b, arrow; a and b, fluores-
cent phalloidin; a9 and b9, myc tag labeling). (c–f9) In T cells ex-
pressing ScarWA, Evl, Fyb/SLAP, and WASP accumulated at
the T cell–bead interface. Jurkat T cells were transfected with
myc-tagged ScarWA, incubated with anti-CD3–coated beads,
fixed, and stained with antibodies to Evl (c), Fyb/SLAP (d),
WASP (e), Arp3 (f), and myc tag (c9–f9). Note that the Arp2/3
complex did not localize at the T cell–bead interface. Bar, 5 mm.The Journal of Cell Biology, Volume 149, 2000 190
tates from Jurkat T cells. WASP immunoprecipitates of
nonstimulated T cell lysates probed with an antibody to
phosphotyrosine revealed three prominent bands running
at z33, 76, and 95 kD (Fig. 9 c). They were also detected
in WASP immunoprecipitates of stimulated T cell lysates
with three additional bands running at z36, 47 and 70 kD
(Fig. 9 c). Given that Nck and SLP-76 are phosphorylated
in T cells, the bands running at 47 and 76 kD may corre-
spond to these proteins. Taken together, these data show
that Fyb/SLAP, SLP-76, Nck, and WASP form a complex
in T cells and that the formation of this complex is en-
hanced upon stimulation of T cells.
Discussion
Fyb/SLAP Is a Novel EVH1-binding Protein
We have identified Fyb/SLAP as a new EVH1 domain–
binding protein. Fyb/SLAP harbors four putative EVH1-
binding motifs, though only one of them binds EVH1 do-
mains in vitro. This functional EVH1-binding site harbors
the acidic amino acid residues, which we have demon-
strated recently to be essential for efficient binding to
EVH1 domains (Niebuhr et al., 1997; Carl et al., 1999).
Whether or not the other candidate EVH1-binding sites in
Fyb/SLAP are important for function(s) in vivo remains to
be determined.
EVH1 domains have emerged recently as important me-
diators of the subcellular localization of Ena/VASP family
proteins, which are thought to be potential regulators of
actin dynamics (Chakraborty et al., 1995; Gertler et al.,
1996; Laurent et al., 1999; Carl et al., 1999). Given that
EVH1-binding proteins recruit Ena/VASP family proteins
to focal contacts (Gertler et al., 1996; for references see
Beckerle, 1997), and based on our observations showing
the restricted localization of Fyb/SLAP to lamellipodia of
spreading platelets and at the interface between T cell and
anti-CD3–coated beads, we suggest that Fyb/SLAP re-
cruits Ena/VASP family proteins to sites where remodel-
ing of the actin cytoskeleton is required in platelets and T
cells. However, we cannot exclude that other as-yet uni-
dentified proteins harboring EVH1-binding sites are in-
volved in this process.
Fyb/SLAP Is a Constituent of a Complex that Links 
TCR Signaling to Reorganization of the
Actin Cytoskeleton
Engagement of the TCR leads to the formation of actin-sup-
ported signaling, which serves to coordinate downstream
events such as proliferation and secretion of cytokines. Sev-
eral lines of evidence support a role of WASP in TCR-
dependent rearrangement of the actin cytoskeleton. Anti-
gen-receptor induced capping is severely impaired in WASP
knockout T cells (Snapper et al., 1998). Furthermore, actin
reorganization in response to CD3-mediated stimulation is
inhibited in human Wiskott-Aldrich syndrome T cells (Gal-
lego et al., 1997). We showed that Fyb/SLAP and WASP lo-
calize to the interface between T cell and anti-CD3–coated
beads and Fyb/SLAP, SLP-76, and Nck can be identified in
WASP immunoprecipitates. In activated T cells, Nck, Vav,
and SLP-76 form a trimolecular complex (Bubeck Warden-
burg et al., 1998). Moreover, SLP-76 interacts with Fyb/
SLAP (Da Silva et al., 1997; Musci et al., 1997), whereas
Nck binds directly to WASP (Rivero-Lezcano et al., 1995).
Therefore, our data are consistent with the possibility that
Fyb/SLAP interacts through a molecular chain with WASP
(Fig. 10 a, red highlighted proteins).
Figure 9. (a) Fyb/SLAP coimmunoprecipitates with WASP. Ly-
sates of activated Jurkat T cells were incubated with the WASP-
specific antiserum Fus3. Immune complexes were collected using
protein A–agarose. Bound proteins were resolved by SDS-
PAGE, blotted, and probed with polyclonal antibodies #51 to
Fyb/SLAP. (lane 1) Cell extract of activated Jurkat T cells; (lane
2) immunoprecipitation with a nonimmune serum; and (lane 3)
immunoprecipitation using a WASP-specific antiserum. (b) Fyb/
SLAP, SLP-76, Nck, and WASP form a multiprotein complex in
Jurkat T cells. Lysates from nonstimulated (NST) or stimulated
(ST) Jurkat T cells were immunoprecipitated using the WASP
mAb #67B4, resolved by SDS-PAGE, blotted, and probed with
antibodies to Fyb/SLAP, SLP-76, and Nck. As negative control,
lysates were immunoprecipitated using an antibody to a bacterial
protein. To exclude nonspecific trapping, WASP immunoprecipi-
tated from lysates of activated T cells were probed using a zyxin
mAb. (c) The stimulation of Jurkat T cells results in the associa-
tion of additional tyrosine-phosphorylated proteins with the
complex. WASP immunoprecipitates from lysates of nonstimu-
lated (NST) or stimulated (ST) Jurkat T cells were resolved by
SDS-PAGE and probed with an antibody to phosphotyrosine.
Note the appearance of three additional bands in stimulated T
cells. hc, heavy chain; lc, light chain. Molecular weight markers
are indicated on the left in (a and b) and on the right in (c).Krause et al. TCR Signaling to the Actin Cytoskeleton 191
Previous investigations using the Listeria model system
have clearly demonstrated that at least two host cell compo-
nents are required for an efficient actin tail formation: Ena/
VASP family proteins (Smith et al., 1996; Niebuhr et al.,
1997; Laurent et al., 1999) and Arp2/3 complex (Welch et
al., 1998; Loisel et al., 1999; May et al., 1999). In this work
we show that both components are also essential for an effi-
cient actin rearrangement in activated T cells. We propose a
model in which a complex composed of Fyb/SLAP, SLP-76,
Nck, and WASP brings together Ena/VASP family proteins
and the Arp2/3 complex, and suggest that this macromolec-
ular assembly links TCR signaling to the remodeling of the
actin cytoskeleton (Fig. 10 a). Our hypothesis is consistent
with the following observations. First, a signaling pathway
similar to the TCR-signaling cascade mediates collagen-
induced activation of platelets. In addition, immunoprecipi-
tation studies demonstrated the association of SLP-76 with
Fyb/SLAP, Vav, Fyn, Lyn, and the FcR g-chain in platelets
stimulated with a collagen-related peptide (Watson and
Gibbins, 1998; Gross et al., 1999), suggesting that hemato-
poietic cells may use a common signal transduction pathway
to link cell activation to the reorganization of the actin cy-
toskeleton. Second, vaccinia virus, which subverts the actin
polymerization machinery to move inside infected cells, re-
cruits Nck and N-WASP at the site of actin assembly, indi-
cating that the signal transduction pathway involving Nck
and N-WASP plays a key role in this process (Frischknecht
et al., 1999).
Figure 10. (a) Model de-
scribing intermolecular inter-
actions and signal transduc-
tion pathways leading to the
cytoskeletal remodeling and
T cell activation upon TCR
ligation (adapted from Ko-
retzky, 1997). Ena/VASP
family proteins and WASP
are linked through a molecu-
lar chain formed by Fyb/
SLAP, SLP-76, and Nck (red
highlighted proteins) to the T
cell–bead interface (see text
for further details). The
green line in the Fyb/SLAP
molecule indicates the EVH1
domain–binding site. (b)
Schematic representation of
the proteins involved in the
actin-based motility of Liste-
ria monocytogenes showing
the recruitment of Ena/
VASP family proteins and
Arp2/3 complex to the bacte-
rial surface protein ActA.The Journal of Cell Biology, Volume 149, 2000 192
How Is the Activity of the Complex Regulated?
The cytoskeletal reorganization occurring in response to
antigen-receptor engagement requires the coordination of
the functions of the proteins involved in this process (Fig.
10 a, red highlighted proteins). T cell activation results in
the formation of a complex between Fyb/SLAP and SLP-
76, and we have demonstrated that this complex also con-
tains WASP and Nck. Although we favor a model in which
Fyb/SLAP, SLP-76, Nck, and WASP form a complex upon
T cell activation, our data show that this complex, al-
though at low levels, is also present in nonstimulated T
cells. This result can be explained in at least two ways.
First, because Jurkat T cells and not primary T cells were
used for this study, it is not unlikely that Jurkat T cells are
in a state of basal activation, which results in the formation
of small amounts of the complex. This is consistent with
previous findings that basal levels of tyrosine phosphoryla-
tion of Fyb/SLAP could be observed in nonstimulated Jur-
kat T cells resulting in binding to SLP-76. This interaction
was found to increase upon T cell stimulation (Musci et al.,
1997). Second, the complex present in nonstimulated T
cells might be in an inactive state, which upon TCR en-
gagement, might be converted into an active state. This
idea is consistent with our observation that upon T cell ac-
tivation, additional tyrosine-phosphorylated proteins are
recruited to the complex. Although our data do not permit
us to prove that the complex present in nonstimulated T
cells is activated upon TCR signaling, we clearly show that
T cell activation results in the enhancement of the com-
plex formation.
The complex may be regulated at different levels. First,
because in T cells Fyb/SLAP also interacts with VASP, it
is possible that a link between Ena/VASP proteins and
WASP–Arp2/3 is formed upon T cell activation, resulting
in actin cup formation. This possibility is consistent with
our observations showing that inhibition of the binding of
Ena/VASP to Fyb/SLAP or Arp2/3 complex to WASP
leads to inhibition of actin cup formation. 
Second, the binding of WASP family proteins to the
Arp2/3 complex activates its actin nucleation activity (Ma-
chesky et al., 1999; Rohatgi et al., 1999; Winter et al., 1999;
Yarar et al., 1999). Moreover, given that WASP family
proteins interact with Cdc42, it is possible that the associa-
tion of WASP with the Arp2/3 complex, or its actin nucle-
ation activity is regulated by Cdc42.
Third, the complex might be recruited to the engaged
TCR. In support of this idea are the following findings: the
activated TCR is recruited to pp36/LAT (Xavier et al.,
1998; Zhang et al., 1998b). In addition, LAT is found in
immunoprecipitates of SLP-76 only in activated T cells
(Motto et al., 1996). Moreover, we observed the appear-
ance of a 36-kD band in WASP immunoprecipitates of ac-
tivated T cells.
Fourth, the complex might be regulated through the associ-
ation with additional proteins. We consistently found an addi-
tional phosphorylated protein of z70 kD in WASP immuno-
precipitates of activated T cells, which might represent the
tyrosine kinases ZAP-70 or Fyn-R (Da Silva and Rudd, 1993).
The Ena/VASP Enigma
This and other reports (Niebuhr et al., 1997; Rottner et al.,
1999; Loisel et al., 1999) clearly show that Ena/VASP pro-
teins act as positive regulators during remodeling of the
actin cytoskeleton. However, Aszódi et al. (1999) recently
showed that VASP-null platelets aggregate faster than
wild-type platelets. Furthermore, we have observed that
Ena/VASP proteins appear to retard cell motility in Rat2
fibroblasts and in cells derived from Mena/VASP double
knockout mice (Bear, J.E., I. Libova, J.J. Loureiro, J. Weh-
land, and F.B. Gertler, manuscript submitted for publica-
tion; Bear, J.E., R. Fässler, and F.B. Gertler, unpublished
observations). Although in both reports the Ena/VASP
proteins are interpreted as having a negative regulatory
function, in neither case was a direct assay of actin remod-
elling performed. However, it is likely that Ena/VASP
proteins play a variety of roles depending on cell type, sub-
cellular compartment, interacting proteins, or the regula-
tory pathway in which they are involved. Future studies
will certainly help us to better understand the function of
this important protein family.
Conclusions
Spatial and temporal segregation of signal transduction
molecules induces a cascade of events culminating in the
activation and proliferation of lymphocytes. Focused reor-
ganization of the actin cytoskeleton at the T cell/APC con-
tact site is essential for successful T cell activation. Despite
a wealth of knowledge on TCR signaling, it is only par-
tially understood how the signals originating from an en-
gaged TCR are linked to the rearrangement of the actin
cytoskeleton. Here we provide evidence that proteins of
the Ena/VASP family and the WASP–Arp2/3 complex are
recruited to complexes that are targeted to sites of actin
reorganization in activated T cells. This scenario is remi-
niscent of the actin tail formation induced by Listeria
monocytogenes, which utilizes a deregulated system in
which the ActA protein recruits Ena/VASP proteins and
the Arp2/3 complex to the bacterial surface to generate
new actin filaments for propelling the bacteria forward
(Fig. 10 b). Therefore, we speculate that upon TCR liga-
tion, T cells induce the regulated assembly of a complex
that results in the juxtaposition of Ena/VASP proteins and
the Arp2/3 complex, thereby inducing temporally and spa-
tially restricted actin nucleation and assembly. To our
knowledge this is the first demonstration of a direct con-
nection between external TCR signaling and some of the
key players involved in actin remodeling. The specific in-
sights we have presented into the molecular basis of the
formation of the actin collar at the T cell–APC interface
may prove to be useful for the development of new treat-
ments of inflammational and other disorders of the im-
mune system. We suggest that similar complexes, whose
functions are subjected to different regulatory pathways,
are involved in actin-based processes such as lamellipodia
and filopodia formation.
The authors thank Dr. Susanne Pistor (Gesellschaft für Biotechnologische
Forschung [GBF], Braunschweig, Germany) for the ActA F . A mutant
and the Arp3 antibody; Dr. Jonathan M.J. Derry (Immunex Corp., Seat-
tle, WA) for the generous gift of the anti-WASP antiserum Fus3; Dr.
Ronald Frank (GBF) for peptide scans; Dr. Laura M. Machesky (Univer-
sity of Birmingham, Birmingham, UK) for the Scar1 constructs; Dr. Sieg-
fried Weiss (GBF) for the anti-CD3 mAb (TR66); Dr. Ravi Salgia (Dana-
Farber Cancer Institute, Harvard Medical School, Boston, MA) forKrause et al. TCR Signaling to the Actin Cytoskeleton 193
anti–Vav-30 mAbs; and Dr. H. Faulstich (Max Planck Institute, Heidel-
berg, Germany) for the kind gift of CY-3 phalloidin. We are grateful to
Dr. Thomas Harder (Basel Institute for Immunology, Basel, Switzerland)
for advice on the bead assay and to Dr. Uwe D. Carl (GBF) for discussion.
We thank Petra Hagendorff, Ellruth Müller, and Maria Höxter for techni-
cal assistance. We also thank the Resource Centre of the German Human
Genome Project at the Max-Planck-Institute for Molecular Genetics
(Berlin, Germany) for providing the EST clones (IMAGE clone ID
221953; IMAGp998F02441). 
J. Wehland is supported by the Deutsche Forschungsgemeinschaft
(WE 2047/5-1) and the Fonds der Chemischen Industrie. F.B. Gertler is
supported by the National Institutes of Health grant GM58801.
Submitted: 16 November 1999
Revised: 2 February 2000
Accepted: 24 February 2000
References
Abel, K., A. Lingnau, K. Niebuhr, J. Wehland, and U. Walter. 1996. Mono-
clonal antibodies against the focal adhesion protein VASP revealing
epitopes involved in the interaction with two VASP binding proteins and
VASP phosphorylation. Eur. J. Cell Biol. 69(Suppl. 42):39a.
Aszódi, A., A. Pfeifer, M. Ahmad, M. Glauner, X.-H. Zhou, L. Ny, K.-E.
Andersson, B. Kehrel, S. Offermanns, and R. Fässler. 1999. The vasodilator-
stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-medi-
ated inhibition of agonist induced platelet aggregation but is dispensable for
smooth muscle function. EMBO (Eur. Mol. Biol. Organ.) J. 18:37–48.
Bachmann, C., L. Fischer, U. Walter, and M. Reinhard. 1999. The EVH2 do-
main of the vasodilator-stimulated phosphoprotein mediates tetrameriza-
tion, F-actin binding, and actin bundle formation. J. Biol. Chem. 274:23549–
23557.
Beckerle, M.C. 1997. Zyxin: zinc fingers at sites of cell adhesion. Bioessays. 19:
949–957.
Brindle, N.P.J., M.R. Holt, J.E. Davies, C.J. Price, and D.R. Critchley. 1996.
The focal-adhesion vasodilator-stimulated phosphoprotein (VASP) binds to
the proline-rich domain in vinculin. Biochem. J. 318:753–757.
Bubeck Wardenburg, J., R. Pappu, J.-Y. Bu, B. Mayer, J. Chernoff, D. Strauss,
and A.C. Chan. 1998. Regulation of PAK activation and the T-cell cytoskel-
eton by the linker protein SLP-76. Immunity. 9:607–616.
Carl, U.D., M. Pollmann, E. Orr, F.B. Gertler, T. Chakraborty, and J. Wehland.
1999. Aromatic and basic residues within the EVH1 domain of VASP spec-
ify its interaction with proline-rich ligands. Curr. Biol. 9:715–718.
Chakraborty, T., F. Ebel, E. Domann, K. Niebuhr, B. Gerstel, S. Pistor, C.J.
Temm-Grove, B.M. Jockusch, M. Reinhard, U. Walter, and J. Wehland.
1995. A focal adhesion factor directly linking intracellularly motile Listeria
monocytogenes and Listeria ivanovii to the actin-based cytoskeleton of
mammalian cells. EMBO (Eur. Mol. Biol. Organ.) J. 14:1314–1321.
Clements, J.L., N.J. Boerth, J.R. Lee, and G.A. Koretzky. 1999. Integration of
T cell receptor-dependent signaling pathways by adapter proteins. Annu.
Rev. Immunol. 17:89–108.
Crespo, P., K.E. Schuebel, A.A. Ostrom, J.S. Gutkind, and X.R. Bustelo. 1997.
Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the
vav proto-oncogene product. Nature. 385:169–172.
Da Silva, A.J., and C.E. Rudd. 1993. A 72-kilodalton fyn related polypeptide
(p72fyn-R) binds to the antigen receptor/CD3 (TcR/CD3) complex. J. Biol.
Chem. 268:16537–16543.
Da Silva, A.J., Z. Li, C. De Vera, E. Canto, P. Findell, and C.E. Rudd. 1997.
Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-con-
taining leukocyte protein 76 and modulates interleukin 2 production. Proc.
Natl. Acad. Sci. USA. 94:7493–7498.
Derry, J.M., H.D. Ochs, and U. Francke. 1994. Isolation of a novel gene mu-
tated in Wiskott-Aldrich syndrome. Cell. 78:635–644.
Derry, J.M., P. Wiedemann, P. Blair, Y. Wang, J.A. Kerns, V. Lemahieu, V.L.
Godfrey, J.E. Wilkinson, and U. Francke. 1995. The mouse homolog of the
Wiskott-Aldrich syndrome protein (WASP) gene is highly conserved and
maps near the scurfy (sf) mutation on the X chromosome. Genomics. 29:
471–477.
Domann, E., J. Wehland, M. Rohde, S. Pistor, M. Hartl, W. Goebel, M. Lei-
meister-Wächter, M. Wuenscher, and T. Chakraborty. 1992. A novel bacte-
rial virulence gene in Listeria monocytogenes required for host cell microfila-
ment interaction with homology to the proline-rich region of vinculin.
EMBO (Eur. Mol. Biol. Organ.) J. 11:1981–1990.
Frank, R. 1992. Spot synthesis: an easy technique for the positionally address-
able, parallel chemical synthesis on a membrane support. Tetrahedron. 48:
9217–9232.
Friederich, E., K. Vancompernolle, C. Huet, M. Goethals, J. Finidori, J. Vande-
kerckhove, and D. Louvard. 1992. An actin-binding site containing a con-
served motif of charged amino acid residues is essential for the morphogenic
effect of villin. Cell. 70:81–92.
Frischknecht, F., V. Moreau, S. Rottger, S. Gonfloni, I. Reckmann, G. Superti-
Furga, and M. Way. 1999. Actin-based motility of vaccinia virus mimics re-
ceptor tyrosine kinase signalling. Nature. 401:926–929.
Gallego, M.D., M. Santamaría, J. Peña, and I.J. Molina. 1997. Defective actin
reorganization and polymerization of Wiskott-Aldrich T-cells in response to
CD3-mediated stimulation. Blood. 90:3089–3097.
Geiger, B., D. Rosen, and G. Berke. 1982. Spatial relationships of microtubule-
organizing centers and the contact area of cytotoxic T-lymphocytes and tar-
get cells. J. Cell Biol. 95:137–143.
Gertler, F.B., K. Niebuhr, M. Reinhard, J. Wehland, and P. Soriano. 1996.
Mena, a relative of VASP and Drosophila Enabled, is implicated in the con-
trol of microfilament dynamics. Cell. 87:227–239.
Gross, B.S., J.R. Lee, J.L. Clements, M. Turner, V.L.J. Tybulewcz, P.R. Findell,
G.A. Koretzky, and S.P. Watson. 1999. Tyrosine phosphorylation of SLP-76
is downstream of Syk following stimulation of the collagen receptor in plate-
lets. J. Biol. Chem. 274:5963–5971.
Han, J., B. Das, W. Wie, L. Van Aelst, R.D. Mosteller, R. Khosravi-Far, J.K.
Westwick, C.J. Der, and D. Broek. 1997. Lck regulates Vav activation of
members of the Rho family of GTPases. Mol. Cell. Biol. 17:1346–1353.
Hüttelmaier, S., B. Harbeck, O. Steffens, T. Messerschmidt, S. Illenberger, and
B.M. Jockusch. 1999. Characterization of the actin binding properties of the
vasodilator-stimulated phosphoprotein VASP. FEBS Lett. 451:68–74.
Jackman, J.K., D.G. Motto, Q. Sun, M. Tanemoto, C.W. Turck, G.A. Peltz,
G.A. Koretzky, and P.R. Findell. 1995. Molecular cloning of SLP-76, a 76-
kDa tyrosine phosphoprotein associated with Grb2 in T-cells. J. Biol. Chem.
270:7029–7032.
Jockusch, B.M., P. Bubeck, K. Giehl, M. Kroemker, J. Moschner, M. Rothke-
gel, M. Rüdiger, K. Schlüter, G. Stanke, and J. Winkler. 1995. The molecular
architecture of focal adhesions. Annu. Rev. Cell Dev. Biol. 11:379–416.
Kang, F., R.O. Laine, M.R. Bubb, F.S. Southwick, and D.L. Purich. 1997. Profi-
lin interacts with the Gly-Pro-Pro-Pro-Pro-Pro sequences of vasodilator-
stimulated phosphoprotein (VASP): implications for actin-based Listeria
motility.  Biochemistry. 36:8384–8392.
Kelleher, J.F., S.J. Atkinson, and T.D. Pollard. 1995. Sequences, structural
models and subcellular localization of the actin-related proteins Arp2 and
Arp3 from Acanthamoeba. J. Cell Biol. 131:385–397.
Kocks, C., E. Gouin, M. Tabouret, P. Berche, H. Ohayon, and P. Cossart. 1992.
L. monocytogenes-induced actin assembly requires the actA gene product, a
surface protein. Cell. 68:521–531.
Koretzky, G.A. 1997. The role of Grb2-associated proteins in T-cell activation.
Immunol. Today. 18:401–406.
Kreft, J., M. Dumbsky, and S. Theiss. 1995. The actin-polymerization protein
from Listeria ivanovii is a large repeat protein which shows only limited
amino acid sequence homology to ActA from Listeria monocytogenes.
FEMS Microbiol. Lett. 126:113–122.
Kupfer, A., S.L. Swain, and S.J. Singer. 1987. The specific interaction of helper
T cells and antigen-presenting B cells. J. Exp. Med. 165:1565–1580.
Kupfer, A., T.R. Mosmann, and H. Kupfer. 1991. Polarized expression of cy-
tokines in cell conjugates of helper T-cells and splenic B cells. Proc. Natl.
Acad. Sci. USA. 88:775–779.
Lanier, L.M., M.A. Gates, W. Witke, S. Menzies, A.M. Wehman, J.D. Macklis,
D. Kwiatkowski, P. Soriano, and F.B. Gertler. 1999. Mena is required for
neurulation and commissure formation. Neuron. 22:313–325.
Lanzavecchia, A., and D. Scheidegger. 1987. The use of hybrid hybridomas to
target human cytotoxic T lymphocytes. Eur. J. Immunol. 17:105–111.
Lasa, I., V. David, E. Gouin, J.-B. Marchand, and P. Cossart. 1995. The amino-
terminal part of ActA is critical for the actin-based motility of Listeria
monocytogenes; the central proline-rich region acts as a stimulator. Mol. Mi-
crobiol. 18:425–436.
Lasa, I., E. Gouin, M. Goethals, K. Vancompernolle, V. David, J. Vandekerck-
hove, and P. Cossart. 1997. Identification of two regions in the N-terminal
domain of ActA involved in the actin comet tail formation by Listeria mono-
cytogenes. EMBO (Eur. Mol. Biol. Organ.) J. 16:1531–1540.
Laurent, V., T.P. Loisel, B. Harbeck, A. Wehman, L. Gröbe, B.M. Jockusch, J.
Wehland, F.B. Gertler, and M.-F. Carlier. 1999. Role of proteins of the Ena/
VASP family in actin-based motility of Listeria monocytogenes. J. Cell Biol.
144:1245–1258.
Loisel, T.P., R. Boujemaa, D. Pantaloni, and M.F. Carlier. 1999. Reconstitution
of actin-based motility of Listeria and Shigella using pure proteins. Nature.
401:613–616.
Lowin-Kropf, B., V.S. Shapiro, and A. Weiss. 1998. Cytoskeletal polarization of
T-cells is regulated by an immunoreceptor tyrosine-based activation motif-
dependent mechanism. J. Cell Biol. 140:861–871.
Macalma, T., J. Otte, M.E. Hensler, S.M. Bockholt, H.A. Louis, M. Kalff-
Suske, K.H. Grzeschik, D. von der Ahe, and M.C. Beckerle. 1996. Molecular
characterization of human zyxin. J. Biol. Chem. 271:31470–31478.
Machesky, L.M., and R.H. Insall. 1998. Scar1 and the related Wiskott-Aldrich
syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3
complex. Curr. Biol. 8:1347–1356.
Machesky, L.M., E. Reeves, F. Wientjes, F.J. Mattheyse, A. Grogan, N.F.
Totty, A.L. Burlingame, J.J. Hsuan, and A.W. Segal. 1997. Mammalian ac-
tin-related 2/3 complex localizes to regions of lamellipodial protrusion and is
composed of evolutionary conserved proteins. Biochem. J. 328:105–112.
Machesky, L.M., R.D. Mullins, H.N. Higgs, D.A. Kaiser, L. Blanchoin, R.C.
May, M.E. Hall, and T.D. Pollard. 1999. Scar, a WASp-related protein, acti-
vates nucleation of actin filaments by the Arp2/3 complex. Proc. Natl. Acad.The Journal of Cell Biology, Volume 149, 2000 194
Sci. USA. 96:3739–3744.
May, R.C., M.E. Hall, H.N. Higgs, T.D. Pollard, T. Chakraborty, J. Wehland,
L.M. Machesky, and A.S. Sechi. 1999. The Arp2/3 complex is essential for
the actin-based motility of Listeria monocytogenes. Curr. Biol. 9:759–762.
Motto, D.G., S.E. Ross, J.K. Jackman, Q. Sun, A.L. Olson, P.R. Findell, and
G.A. Koretzky. 1994. In vivo association of Grb2 with pp116, a substrate of
the T cell antigen receptor-activated protein tyrosine kinase. J. Biol. Chem.
269:21608–21613.
Motto, D.G., S.E. Ross, W. Jun, L.R. Hendricks-Taylor, and G.A. Koretzky.
1996. Implication of the GRB2-associated phosphoprotein SLP-76 in T cell
receptor-mediated interleukin 2 production. J. Exp. Med. 183:1937–1943.
Musci, M.A., L.R. Hendricks-Taylor, D.G. Motto, M. Paskind, J. Kamens,
C.W. Turck, and G.A. Koretzky. 1997. Molecular cloning of SLAP-130, an
SLP-76-associated substrate of the T cell antigen receptor-stimulated pro-
tein tyrosine kinases. J. Biol. Chem. 272:11674–11677.
Niebuhr, K., T. Chakraborty, M. Rhode, T. Gazlig, B. Jansen, P. Köllner, and J.
Wehland. 1993. Localization of the ActA polypeptide of Listeria monocy-
togenes in infected tissue culture cell lines: ActA is not associated with actin
comets. Infect. Immun. 61:2693–2802.
Niebuhr, K., F. Ebel, R. Frank, M. Reinhard, E. Domann, U.D. Carl, U.
Walter, F.B. Gertler, J. Wehland, and T. Chakraborty. 1997. A novel pro-
line-rich motif present in ActA of Listeria monocytogenes and cytoskeletal
proteins is the ligand for the EVH1 domain, a protein module present in the
Ena/VASP family. EMBO (Eur. Mol. Biol. Organ.) J. 16:5433–5444.
Niebuhr, K., A. Lingnau, R. Frank, and J. Wehland. 1998. Rapid procedures for
preparing monoclonal antibodies and identifying their epitopes. In Cell Bi-
ology: A Laboratory Handbook. Vol. 2. J. Celis, editor. Academic Press, San
Diego, CA. 398–403.
Nonoyama, S., and H.D. Ochs. 1998. Characterization of the Wiskott-Aldrich
syndrome protein and its role in the disease. Curr. Opin. Immun. 10:407–
412.
Olson, M.F., N.G. Pasteris, J.L. Gorski, and A. Hall. 1996. Faciogenital dyspla-
sia protein (FGD1) and Vav, two related proteins required for normal em-
bryonic development, are upstream regulators of Rho GTPases. Curr. Biol.
6:1628–1633.
Pantaloni, D., and M.F. Carlier. 1993. How profilin promotes actin filament as-
sembly in the presence of thymosin b4. Cell. 75:1007–1014.
Penninger, J.M., and G.R. Crabtree. 1999. The actin cytoskeleton and lympho-
cyte activation. Cell. 96:9–12.
Pistor, S., T. Chakraborty, U. Walter, and J. Wehland. 1995. The bacterial actin
nucleator protein ActA of Listeria monocytogenes contains multiple binding
sites for host microfilament proteins. Curr. Biol. 5:517–525.
Raab, M., H. Kang, A. da Silva, X. Zhu, and C.E. Rudd. 1999. FYN-T-FYB-
SLP-76 interactions define a T-cell receptor zeta/CD3-mediated tyrosine
phosphorylation pathway that up-regulates interleukin 2 transcription in
T-cells.  J. Biol. Chem. 274:21170–21179.
Reinhard, M., M. Halbrügge, U. Scheer, C. Wiegand, B.M. Jockusch, and U.
Walter. 1992. The 46/50 kDa phosphoprotein VASP purified from human
platelets is a novel protein associated with actin filaments and focal contacts.
EMBO (Eur. Mol. Biol. Organ.) J. 11:2063–2070.
Reinhard, M., K. Giehl, K. Abel, C. Haffner, T. Jarchau, V. Hoppe, B.M. Jock-
usch, and U. Walter. 1995. The proline-rich focal adhesion and microfilament
protein VASP is a ligand for profilins. EMBO (Eur. Mol. Biol. Organ.) J. 14:
1583–1589.
Reinhard, M., M. Rüdiger, B.M. Jockusch, and U. Walter. 1996. VASP interac-
tion with vinculin: a recurring theme of interactions with proline-rich motifs.
FEBS Lett. 399:103–107.
Rivero-Lezcano, O.M., A. Marcilla, J.H. Sameshima, and K.C. Robbins. 1995.
Wiskott-Aldrich syndrome protein physically associates with Nck through
Src homology 3 domains. Mol. Cell. Biol. 15:5725–5731.
Rohatgi, R., L. Ma, H. Miki, M. Lopez, T. Kirchhausen, T. Takenawa, and M.
Kirschner. 1999. The interaction between N-WASP and the Arp2/3 complex
links Cdc42-dependent signals to actin assembly. Cell. 97:1–20.
Rottner, K., B. Behrendt, J.V. Small, and J. Wehland. 1999. VASP dynamics
during lamellipodia protrusion. Nat. Cell Biol. 1:321–322.
Ryser, J.-E., E. Rungger-Brändle, C. Chaponnier, G. Gabbiani, and P. Vassalli.
1982. The area of attachment of cytotoxic T lymphocytes to their target cells
shows high motility and polarization of actin, but not myosin. J. Immun. 128:
1159–1162.
Sadler, I., A.W. Crawford, J.W. Michelsen, and M.C. Beckerle. 1992. Zyxin and
cCRP: two interactive LIM domain proteins associated with the cytoskele-
ton. J. Cell Biol. 119:1573–1587.
Sattler, M., M.A. Durstin, D.A. Frank, K. Okuda, K. Kaushansky, R. Salgia,
and J.D. Griffin. 1995. The thrombopoietin receptor c-MPL activates JAK2
and TYK2 tyrosine kinases. Exp. Hematol. 23:1040–1048.
Secrist, J.P., L.A. Burns, L. Karnitz, G.A. Koretzky, and R.T. Abraham. 1993.
Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervana-
date, on T-cell activation events. J. Biol. Chem. 268:5886–5893.
Smith, G.A., J.A. Theriot, and D.A. Portnoy. 1996. The tandem repeat domain
in the Listeria monocytogenes ActA protein controls the rate of actin-based
motility, the percentage of moving bacteria, and the localization of vasodila-
tor-stimulated phosphoprotein and profilin. J. Cell Biol. 135:647–660.
Snapper, S.B., F.S. Rosen, E. Mizoguchi, P. Cohen, W. Khan, C.-H. Liu, T.L.
Hagemann, S.-P. Kwan, R. Ferrini, L. Davidson, et al. 1998. Wiskott-Aldrich
syndrome protein-deficient mice reveal a role for WASP in T but not B cell
activation. Immunity. 9:81–91.
Symons, M., J.M.J. Derry, B. Karlak, S. Jiang, V. Lemahieu, F. McCormick, U.
Francke, and A. Abo. 1996. Wiskott-Aldrich syndrome protein, a novel ef-
fector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell.
84:723–734.
Takubo, T., M. Hino, K. Suzuki, and N. Tatsumi. 1998. Localization of myosin,
actin, alpha-actinin, tropomyosin, and vinculin in surface-activated, spread-
ing human platelets. Biotech. Histochem. 73:310–315.
Tuosto, L., F. Michel, and O. Acuto. 1996. p95vav associates with tyrosine-phos-
phorylated SLP-76 in antigen stimulated T cells. J. Exp. Med. 184:1161–1166.
Valitutti, S., M. Dessing, K. Aktories, H. Gallati, and A. Lanzavecchia. 1995.
Sustained signaling leading to T-cell activation results from prolonged T-cell
receptor occupancy. Role of T-cell actin cytoskeleton. J. Exp. Med. 181:577–584.
Van Troys, M., D. Dewitte, M. Goethals, M.-F. Carlier, J. Vanderkerckhove,
and C. Ampe. 1996. The actin binding site of thymosin b4 mapped by muta-
tional analysis. EMBO (Eur. Mol. Biol. Organ.) J. 15:201–210.
Veale, M., M. Raab, Z. Li, A.J. da Silva, S.K. Kraeft, S. Weremowicz, C.C.
Morton, and C.E. Rudd. 1999. Novel isoform of lymphoid adaptor FYN-
T-binding protein (FYB-130) interacts with SLP-76 and up-regulates inter-
leukin 2 production. J. Biol. Chem. 274:28427–28435.
Watson, S.P., and J. Gibbins. 1998. Collagen receptor signalling in platelets: ex-
tending the role of the ITAM. Immunol. Today. 19:260–264.
Weiss, A., and D.R. Littman. 1994. Signal transduction by lymphocyte antigen
receptors. Cell. 76:263–274.
Welch, M.D., A. Iwamatsu, and T.J. Mitchison. 1997a. Actin polymerization is
induced by Arp2/3 protein complex at the surface of Listeria monocytogenes.
Nature. 385:265–269.
Welch, M.D., A.H. DePace, S. Verma, A. Iwamatsu, and T.J. Mitchison. 1997b.
The human Arp2/3 complex is composed of evolutionarily conserved sub-
units and is localized to cellular regions of dynamic actin filament assembly.
J. Cell Biol. 138:375–384.
Welch, M.D., J. Rosenblatt, J. Skoble, D.A. Portnoy, and T.J. Mitchison. 1998.
Interaction between the human Arp2/3 complex and Listeria monocytogenes
ActA protein in actin filament nucleation. Science. 281:105–108.
Wills, Z., J. Bateman, C.A. Korey, A. Comer, and D. Van Vactor. 1999. The ty-
rosine kinase Abl and its substrate enabled collaborate with the receptor
phosphatase Dlar to control motor axon guidance. Neuron. 22:301–312.
Winter, D., T. Lechler, and R. Li. 1999. Activation of the yeast Arp2/3 complex
by bee1p, a WASP-family protein. Curr. Biol. 9:501–504.
Xavier, R., T. Brennan, Q. Li, C. McCormack, and B. Seed. 1998. Membrane
compartmentation is required for efficient T cell activation. Immunity. 8:723–
732.
Yarar, D., W. To, A. Abo, and M.D. Welch. 1999. The Wiskott-Aldrich syn-
drome protein directs actin-based motility by stimulating actin nucleation
with the Arp2/3 complex. Curr. Biol. 9:555–558.
Zhang, W., J. Sloan-Lancaster, J. Kitchen, R.P. Trible, and L.E. Samelson.
1998a. LAT: the ZAP-70 tyrosine kinase substrate that links T-cell receptor
to cellular activation. Cell. 92:83–92.
Zhang, W., R.P. Trible, and L.E. Samelson. 1998b. LAT palmitoylation: its es-
sential role in membrane microdomain targeting and tyrosine phosphoryla-
tion during T-cell activation. Immunity. 9:239–246.